EGG Healthy Pregnancy
A platform for better pregnancy outcomes, powered by AI and science.
EGG Healthy Pregnancy is a health-technology and life-sciences company using artificial intelligence to improve pregnancy outcomes — reducing preterm birth and preeclampsia in the United States and globally. We work as a platform: expressed today through Natally, our first digital therapeutic; extended through AI-enabled blood testing; and carried worldwide through partnerships.
What we're solving
Closing the gap between what we know and what reaches families.
Most of the harm from preterm birth and preeclampsia is preventable — the science already exists. The problem is that proven, evidence-based care doesn't consistently reach the people who need it most, especially in underserved and global settings. EGG Healthy Pregnancy builds the technology that closes that gap: tools that identify modifiable risk early, explain it in plain language, and connect each risk to a guideline-recommended, pregnancy-safe action.
The information on this page is for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
How we work: the platform
One platform, three ways we reach families.
Our work spans two connected areas of capability, plus a path to global impact. Together they let us predict risk, act on it, and confirm that care is working.
Digital therapeutics
We turn evidence-based pregnancy care into software that people actually use. Our digital therapeutics identify modifiable risks early, explain them clearly, and link each one to a pregnancy-safe, guideline-recommended intervention — supported across the pregnancy journey.
Natally is our first digital therapeutic.
See the productAI-enabled blood testing
We use AI-enabled blood testing to measure biological signals of pregnancy risk. This deepens prediction — flagging risk even where clinical factors alone would suggest low risk — and opens a path toward understanding mechanism and tracking whether treatment is working over time.
Global adaptation
Our platform architecture is built to travel. Through partnerships, we adapt our tools for routine antenatal care in other health systems and regions — bringing the same predict-and-act approach to settings with the greatest need.
Our first digital therapeutic
Natally
Natally is EGG Healthy Pregnancy's first digital therapeutic — a digital tool that helps expectant families close the “know-do gap.” It identifies modifiable pregnancy risks early, explains them in plain language, and links each to a pregnancy-safe, guideline-recommended action, with support across the pregnancy journey. It's designed to reach the families who too often go underserved.
Built on validated, licensed science
The science and IP behind the platform.
Our platform is built on rigorously validated, licensed intellectual property — not on claims alone.
Asset 1 — PTB-ARIx, our risk engine
At the core of our digital therapeutics is PTB-ARIx (the Preterm Birth Actionable Risk Index), a patent-protected risk engine we license from leading academic institutions. PTB-ARIx is actionable, not merely predictive: it scores only the risk factors that can be modified, and maps each to a recommended, pregnancy-safe intervention. It was developed and validated at scale by the HOPE Research Consortium, with lead investigators at NYU and the University of Alabama at Birmingham (UAB), and can be computed early in pregnancy. Licensed from NYU and NYU Langone Health.
Asset 2 — AI-enabled blood testing
We license AI-enabled blood-testing technology that measures biological markers of pregnancy risk. It strengthens prediction today, and supports an active program of research into biological mechanism and treatment monitoring. The testing runs through established laboratory partners, including Providence Health.
Asset 3 — The platform & partnership model
Beyond any single tool, our asset is the platform itself: an architecture that takes validated science and turns it into software that scales — across populations, across care settings, and across borders through partnership and licensing. We don't operate our own lab; we scale through partners, which lets us extend reach without rebuilding infrastructure.
Global impact through partnership
Bringing the platform to where it's needed most.
We extend our platform globally through partnership rather than direct sales. Our anchor international collaboration adapts our architecture for routine antenatal care — screening for high blood pressure and preeclampsia risk, and connecting families to pregnancy-safe interventions — in settings where the need is greatest. This work is led with academic and clinical partners, including the Aga Khan University (AKU) collaboration through NCD-ACT, where EGG Healthy Pregnancy serves as the technical development partner.
Presented as direction and roadmap, not as a guarantee of outcomes.
Our team
Scientists, builders, and clinicians working toward the same outcome.
EGG Healthy Pregnancy brings together technology leaders, life-sciences operators, and leading researchers in maternal and pregnancy health. Our founding science is led by Dr. Laura Jelliffe-Pawlowski (founding partner), with clinical guidance from advisors including Dr. Akila Subramaniam, and international work co-led with partners such as Dr. Godfrey Katende at Aga Khan University.